Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aoxin Sunshine (Beijing) Technology Co., Ltd. is a specialized medical device company based in Beijing, China, focusing on the research, development, and production of interventional cardiovascular products. As a key subsidiary of Sino Medical Sciences Technology Inc. (Sinomed), the company is primarily recognized for its Sunshine Sirolimus-eluting Coronary Stent System, a drug-device combination used to treat coronary artery disease. In addition to its flagship stent product, Aoxin Sunshine manufactures various percutaneous transluminal coronary angioplasty (PTCA) balloon dilatation catheters. The company's products are widely used in clinical settings across China and are integrated into Sinomed's broader portfolio of cardiovascular solutions. Aoxin Sunshine maintains high-standard manufacturing facilities and continues to contribute to the advancement of interventional cardiology through its specialized product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aoxin Sunshine.